ACRIVON THERAPEUTICS, INC. COMMON STOCK
ACRV -0.86
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 0.0K |
| Cost of Revenue | 0.0K |
| Gross Profit | 0.0K |
| Operating Expense | 9,945.0K |
| Operating I/L | -9,945.0K |
| Other Income/Expense | 1,016.0K |
| Interest Income | 0.0K |
| Pretax | -8,929.0K |
| Income Tax Expense | -1,016.0K |
| Net Income/Loss | -7,913.0K |
Acrivon Therapeutics, Inc. Common Stock
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
